MAR 25, 2021 11:00 AM PDT

The Role of Interferon Gamma Release Assay (IGRA) Testing in the era of COVID-19

Sponsored by: DiaSorin
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Chief, Occupational Health, VA Palo Alto Health Care System and Associate Clinical Professor, Population Health and Epidemiology, Stanford
    Biography

      Dr. Thanassi is an energetic leader with a national and international recognition in infectious diseases, particularly tuberculosis screening and concomitant technical/logistic/operational and financial considerations. She is has been a clinical principal investigator on FDA clinical trials; a published researcher, a clinical and administrative section chief; a national clinical consultant, a VHA national advisor in infectious diseases/policy and IT innovations, and has extensive speaking experience including keynoting national and international conferences. She has worked collaboratively with private, academic and public agencies to develop national health care worker medical policies.


    Abstract

    Date:  March 25, 2021

    Time: 11:00am PDT

     

    This is the second World TB Day and the end of the first full year since the world encountered COVID-19. We have all worked feverishly to manage this pandemic and its consequences. What impact has this new respiratory infectious disease had on the chronic pandemic of tuberculosis? What can we do to avoid mistakes made in the U.S. 35 years ago, when TB rates rose by 20% due to diverted attentions? Can we use this time to actually make progress toward elimination of TB in the U.S.? 

     

    Learning Objectives:

    • Review the impact of the COVID-19 pandemic on tuberculosis incidence, recognition and care
    • Review the recent US public health data on TB and LTBI, including testing and diagnostic methods
    • Review the role of IGRA testing and LTBI treatment in these challenging times

     

     

    Webinars will be available for unlimited on-demand viewing after live event.

     

    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


    Show Resources
    You May Also Like
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JAN 21, 2021 8:00 AM PST
    JAN 21, 2021 8:00 AM PST
    Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
    NOV 05, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 05, 2020 7:00 AM PST
    DATE: Date needed, 2020 TIME: Time needed Exosomes are a population of naturally occurring mobile, membrane-limited, 30 – 100 nm in diameter, extracellular vesicles containing a large...
    NOV 19, 2020 8:00 AM GMT
    C.E. CREDITS
    NOV 19, 2020 8:00 AM GMT
    Date: November 19, 2020 Time: 12:00am (PDT), 9:00am (CET), 4:00pm (SGT) We present split-FISH, a multiplexed fluorescence in situ hybridization method that leverages a split-probe design to...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    Loading Comments...
    Show Resources
    Attendees
    • See more